本页面由Tiger Trade Technology Pte. Ltd.提供服务

Revolution Medicines, Inc.

192.79
-1.1650-0.60%
成交量:19.38万
成交额:3,726.24万
市值:413.21亿
市盈率:-21.61
高:193.58
开:191.57
低:190.83
收:193.95
52周最高:224.31
52周最低:47.45
股本:2.14亿
流通股本:1.85亿
量比:1.06
换手率:0.10%
股息:- -
股息率:- -
每股收益(TTM):-8.9212
每股收益(LYR):-5.9502
净资产收益率:-79.09%
总资产收益率:-30.12%
市净率:15.85
市盈率(LYR):-32.40

数据加载中...

2025/06/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/18

重要事件披露

Form 8-K - Current report
2025/06/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/08

重要事件披露

Form 8-K - Current report
2025/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/26

重要事件披露

Form 8-K - Current report
2025/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/26

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities